Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (581-590 of 652) with videos related to

Pageof 66
Sort By:
Cardiovascular Diabetology|April 16, 2017
Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetesMalgorzata Poreba, Magdalena Mostowik, Aleksander Siniarski, et al.
Frontiers in Endocrinology|March 26, 2024
The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgeryAgata Hanna Bryk-Wiązania, Mari Minasyan, Renata Świątkowska-Stodulska, et al.
Atherosclerosis|February 8, 2022
Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosisJakub Siudut, Joanna Natorska, Ewa Wypasek, et al.
Thrombosis Research|September 4, 2019
Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutationsEwa Wypasek, Anna Klukowska, Joanna Zdziarska, et al.
Scientific Reports|July 12, 2020
Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality riskMichał Ząbczyk, Joanna Natorska, Agnieszka Janion-Sadowska, et al.
Thrombosis and Haemostasis|November 13, 2020
Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated EmbolismMichał Ząbczyk, Joanna Natorska, Agnieszka Janion-Sadowska, et al.
Kardiologia Polska|March 13, 2018
Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonistsMałgorzata Konieczyńska, Ewa Sobieraj, Agata H Bryk, et al.
European Journal of Clinical Investigation|July 27, 2021
Isoprostane-8 and GDF-15 as novel markers of post-PE syndrome: Relation with prothrombotic factorsMichał Ząbczyk, Joanna Natorska, Agnieszka Janion-Sadowska, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 18, 2014
Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trialAgata Niżankowska-Jędrzejczyk, Fernanda R Almeida, Alan A Lowe, et al.
Clinical and Translational Allergy|July 21, 2020
Citrullinated histone H3, a marker of extracellular trap formation, is increased in blood of stable asthma patientsPawel Kuczia, Joanna Zuk, Teresa Iwaniec, et al.
Pageof 66

Showing results (581-590 of 652) with videos related to

Sort By:
Pageof 66
Cardiovascular Diabetology|April 16, 2017
Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetesMalgorzata Poreba, Magdalena Mostowik, Aleksander Siniarski, et al.
Frontiers in Endocrinology|March 26, 2024
The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgeryAgata Hanna Bryk-Wiązania, Mari Minasyan, Renata Świątkowska-Stodulska, et al.
Atherosclerosis|February 8, 2022
Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosisJakub Siudut, Joanna Natorska, Ewa Wypasek, et al.
Thrombosis Research|September 4, 2019
Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutationsEwa Wypasek, Anna Klukowska, Joanna Zdziarska, et al.
Scientific Reports|July 12, 2020
Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality riskMichał Ząbczyk, Joanna Natorska, Agnieszka Janion-Sadowska, et al.
Thrombosis and Haemostasis|November 13, 2020
Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated EmbolismMichał Ząbczyk, Joanna Natorska, Agnieszka Janion-Sadowska, et al.
Kardiologia Polska|March 13, 2018
Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonistsMałgorzata Konieczyńska, Ewa Sobieraj, Agata H Bryk, et al.
European Journal of Clinical Investigation|July 27, 2021
Isoprostane-8 and GDF-15 as novel markers of post-PE syndrome: Relation with prothrombotic factorsMichał Ząbczyk, Joanna Natorska, Agnieszka Janion-Sadowska, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 18, 2014
Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trialAgata Niżankowska-Jędrzejczyk, Fernanda R Almeida, Alan A Lowe, et al.
Clinical and Translational Allergy|July 21, 2020
Citrullinated histone H3, a marker of extracellular trap formation, is increased in blood of stable asthma patientsPawel Kuczia, Joanna Zuk, Teresa Iwaniec, et al.
Pageof 66